-
Signature
-
/s/ Sarah Dale, Attorney-in-Fact for Brian Millham
-
Stock symbol
-
CRM
-
Transactions as of
-
May 22, 2024
-
Transactions value $
-
-$472,499
-
Form type
-
4
-
Date filed
-
5/23/2024, 05:13 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CRM |
Common Stock |
Options Exercise |
$380K |
+2.04K |
|
$186.51 |
2.04K |
May 22, 2024 |
Direct |
F1 |
transaction |
CRM |
Common Stock |
Options Exercise |
$434K |
+2.02K |
+98.97% |
$215.17 |
4.06K |
May 22, 2024 |
Direct |
F1 |
transaction |
CRM |
Common Stock |
Options Exercise |
$460K |
+2.11K |
+51.96% |
$218.21 |
6.16K |
May 22, 2024 |
Direct |
F1 |
transaction |
CRM |
Common Stock |
Sale |
-$1.75M |
-6.16K |
-100% |
$283.41 |
0 |
May 22, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2.04K |
-2.86% |
$0.00 |
69.3K |
May 22, 2024 |
Common Stock |
2.04K |
$186.51 |
Direct |
F1, F2 |
transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2.02K |
-9.09% |
$0.00 |
20.2K |
May 22, 2024 |
Common Stock |
2.02K |
$215.17 |
Direct |
F1, F3 |
transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2.11K |
-4.35% |
$0.00 |
46.3K |
May 22, 2024 |
Common Stock |
2.11K |
$218.21 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: